Agios Pharmaceuticals | الدين



Debt تغيير تاريخ
AbbVie USD 69.89B 2.74B 2025-03
Agios Pharmaceuticals USD 48.76M 48.76M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amgen USD 56.2B 1.18B 2025-06
Arrowhead Research USD 388.24M 21.18M 2025-03
Astellas Pharma JPY 831.43B 83.94B 2025-03
AstraZeneca USD 32.84B 1.19B 2025-06
Bayer EUR 39.39B 1.31B 2025-03
Biogen USD 6.59B 296.8M 2025-06
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Daiichi Sankyo JPY 101.33B 97M 2025-03
Eli Lilly USD 39.9B 1.39B 2025-06
Exelixis USD 179.84M 179.84M 2025-06
Gilead Sciences USD 24.95B 6M 2025-06
GlaxoSmithKline GBP 17.35B 1.08B 2025-06
Incyte USD 42.41M 5.29M 2025-06
Ionis Pharmaceuticals USD 1.42B 169.27M 2025-06
Merck USD 34.84B 2.27B 2025-03
Moderna USD 741M 4M 2025-06
Novartis USD 31.27B 12M 2025-03
Novartis USD 31.26B 828M 2024-12
Pfizer USD 60.93B 1.18B 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Roche Holding CHF 34.44B 5.23B 2024-06
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


Agios Pharmaceuticals الدين - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.